Results 251 to 260 of about 2,509,536 (335)

Persian adaptation and validation of the user version of The Mobile Application Rating Scale (uMARS). [PDF]

PLoS One
Kohzadi Z, Rahmatizadeh S, Kohzadi Z, Valizadeh-Haghi S.   +3 more
europepmc   +1 more source

Medical education and the quality of care

Academic Medicine, 1976
openaire   +4 more sources

Quality of life in patients at risk of medullary thyroid carcinoma and followed by a comprehensive medical network: Trends for future evaluations

, 2001
Gilles Freyer, Blandine Ligneau, Martin Schlumberger, Cécile Blandy, B. Conte‐Devolx, V. Trillet-Lenoir, Gilbert Lenoir, Nicole G. Chau, A Dazord   +8 more
openalex   +1 more source

FAM136A depletion induces mitochondrial stress and reduces mitochondrial membrane potential and ATP production

FEBS Open Bio, EarlyView.
FAM136A depletion upregulated ROS production, reduced mitochondrial membrane potential (ΔΨ) and ATP production, and upregulated expression of PCK1, PCK2, HMGCS1, and HMGCS2. The expression of both TOMM22 and TOMM20 was also upregulated. FAM136A depletion reduced HCCS that produce holocytochrome c by combining heme to apocytochrome c, and reduced the ...
Yushi Otsuka, Masato Yano
wiley   +1 more source

Quality of sleep and associated factors among medical interns in public universities in North Ethiopia. [PDF]

Front Psychiatry
Meles DA, Ayele AD, Tsegaberhan H, Mossie TB.   +3 more
europepmc   +1 more source

Pharmacological effects of osimertinib on a chicken chorioallantoic membrane xenograft model with the EGFR exon‐19‐deleted advanced NSCLC mutation

FEBS Open Bio, EarlyView.
Osimertinib reduces angiogenesis and PDL1 expression in in ovo tumors, transforming them into ‘cold tumors’ with lower immune activity. Anatomopathological and transcriptomic analyses highlight its therapeutic impact on tumor biology. This study underscores osimertinib's potential to reshape the tumor microenvironment and provides insights into its ...
David Barthélémy, Arnaud Vigneron, Xavier Rousset, Jérome Guitton, Emmanuel Grolleau, Margaux Raffin, Julie Balandier, Gaëlle Lescuyer, Mathilde Bardou, Florence Geiguer, Sébastien Couraud, Claire Bardel, Jean Viallet, Nazim Benzerdjeb, Léa Payen   +14 more
wiley   +1 more source

A fully automated, expert-perceptive image quality assessment system for whole-body [18F]FDG PET/CT. [PDF]

EJNMMI Res
Zhang C, Gao X, Zheng X, Xie J, Feng G, Bao Y, Gu P, He C, Wang R, Tian J.   +9 more
europepmc   +1 more source

A potential tumor suppressor role of PLK2 in glioblastoma

FEBS Open Bio, EarlyView.
PLK2 was consistently downregulated in GBM tissues. Overexpression of PLK2 in GBM cell lines U87MG and U251 reduced their tumorigenic potential and enhanced cell cycle arrest and apoptosis. Suggesting that PLK2 overexpression could potentially be leveraged as a therapeutic strategy to inhibit tumor progression and enhance apoptosis, providing new ...
Xiangping Xia, Peirui Wang, Hua Xiao, Qishan Ran, Yan Li, Shengtao Yao   +5 more
wiley   +1 more source

Quality of cerebral palsy videos on Chinese social media platforms. [PDF]

Sci Rep
He W, Tang D, Jin Y, Zhang W, Kang Y, Xia Q.   +5 more
europepmc   +1 more source

Identification of inhibitors of the Salmonella FraB deglycase, a drug target

FEBS Open Bio, EarlyView.
A high‐throughput screen was used to identify inhibitors of Salmonella FraB, a drug target. Characterization of top hits (identified after an additional counter screen) revealed that some triazolidines, thiadiazolidines, and triazolothiadiazoles are mixed‐type inhibitors of FraB.
Jamison D. Law, Yuan Gao, Sravya Kovvali, Pankajavalli Thirugnanasambantham, Vicki H. Wysocki, Brian M. M. Ahmer, Venkat Gopalan   +6 more
wiley   +1 more source